Fig. 1: IGF2BP2 is highly expressed in pancreatic cancer, and is associated with clinical outcomes. | Cell Death & Differentiation

Fig. 1: IGF2BP2 is highly expressed in pancreatic cancer, and is associated with clinical outcomes.

From: IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader

Fig. 1: IGF2BP2 is highly expressed in pancreatic cancer, and is associated with clinical outcomes.The alternative text for this image may have been generated using AI.

a Representative immunohistochemistry (IHC) results of IGF2BP2 protein expression from the pancreatic cancer tissue microarray. b Statistical analysis of IHC expression in normal and tumor specimens. c Kaplan–Meier plotter for overall survival based on IGF2BP2 protein expression. d Overall survival based on Pancreatic Adenocarcinoma dataset (TCGA, Provisional) analysis of mRNA levels (high and low). e Analysis of Pan-Cancer RNA seq (pancreatic adenocarcinoma dataset) from Kaplan–Meier plotter (http://kmplot.com/analysis/) also suggests poor overall survival with high expression of IGF2BP2 as compared with the low IGF2BP2 expression group.

Back to article page